Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Jun;127(6):1334-1338.
doi: 10.1002/lary.26443. Epub 2017 Feb 1.

Adjuvant radiotherapy is not supported in patients with verrucous carcinoma of the oral cavity

Suresh Mohan  1 , Sara I Pai  2 , Neil Bhattacharyya  3
Affiliations

Adjuvant radiotherapy is not supported in patients with verrucous carcinoma of the oral cavity

Suresh Mohan et al. Laryngoscope. 2017 Jun.

Abstract

Objective: To analyze the impact of adjuvant radiation therapy (RT) on overall survival (OS) and disease-specific survival (DSS) in patients with verrucous carcinoma (VC) as compared to squamous cell carcinoma (SCC) of the oral cavity.

Study design: Cross-sectional population analysis.

Methods: Cases of nonmetastatic VC/SCC of the oral cavity were extracted from the Surveillance, Epidemiology, and End Results (SEER) database (1988-2013). Kaplan-Meier survivals, stratified according to T stage, were compared between VC and SCC for treatment with or without adjuvant RT.

Results: A total of 18,819 VC/SCC cases were identified. There were 581 (3.1%) VC (mean age 69.6 years, 48.9% female) versus 18,238 (97.0%) SCC (mean age, 65.3, 37.1% female) patients. Verrucous carcinoma patients receiving surgery alone (N = 539) demonstrated a trend toward improved OS versus VC patients receiving surgery and RT (N = 40) (117.0 vs. 71.4 months, respectively, P = 0.119). There was a statistically significant improvement in DSS in VC patients receiving surgery alone (217.2 vs. 110.9 months, P = 0.05). Verrucous carcinoma patients treated with adjuvant RT demonstrated a trend toward a worse OS (71.4 vs. 93.0 months, P = 0.992) and DSS (110.9 vs. 162.3 months, P = 0.275) compared to SCC treated with adjuvant RT, suggesting a different biology and radiosensitivity between VC and SCC.

Conclusion: Verrucous carcinoma treated with adjuvant RT had a worse OS and DSS compared to both VC treated with surgery alone and SCC treated with surgery and adjuvant RT. Consideration should be given to surgical re-section rather than adjuvant RT in patients with positive margins or local recurrence.

Level of evidence: 2C. Laryngoscope, 127:1334-1338, 2017.

Keywords: SEER; T stage; Verrucous carcinoma; cancer; head and neck cancer; oral cavity; radiation therapy; survival.

PubMed Disclaimer

Figures

Fig. 1.
Fig. 1.
(A) Overall survival (P = 0.119), B) Disease-specific survival (P = 0.05) based on overall pooled data for verrucous carcinoma patients treated with or without adjuvant radiation therapy. Cum = cumulative; RT = radiation therapy; Sx = surgery.
Fig. 2.
Fig. 2.
(A) Overall survival (P = 0.992), (B) Disease-specific survival (P = 0.275) based on overall pooled data for verrucous carcinoma versus SCC patients treated with adjuvant radiation therapy. Cum = cumulative; SCC = squamous cell carcinoma; VC = verrucous carcinoma.
See this image and copyright information in PMC

References

    1. Friedell H, Rosenthal L. The etiologic role of chewing tobacco in cancer of the mouth: report of eight cases treated with radiation. J Am Med Assoc 1941;116:2130–2135.
    1. Ackerman LV. Verrucous carcinoma of the oral cavity. Surgery 1948;23: 670–678. - PubMed
    1. Batsakis JG, Hybels R, Crissman JD, Rice DH. The pathology of head and neck tumors: verrucous carcinoma, Part 15. Head Neck Surg 1982;5:29–38. - PubMed
    1. Kraus FT, Perezmesa C. Verrucous carcinoma. Clinical and pathologic study of 105 cases involving oral cavity, larynx and genitalia. Cancer 1966;19:26–38. - PubMed
    1. Koch BB, Trask DK, Hoffman HT, et al. National survey of head and neck verrucous carcinoma: patterns of presentation, care, and outcome. Cancer 2001;92:110–120. - PubMed

MeSH terms